Marvel Biosciences Corp's total assets for Q3 2025 were C$500.51K, an increase of 128.47% from the previous quarter. TSE:MRVL total liabilities were C$3.43M for the fiscal quarter, a -9.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.